logo

For the Inventor, By the Inventor

Yongin, South Korea

Jae-Jin Han

This inventor holds 5 USPTO granted patents and 1 EPO patent. Top assignees: Cellsafe Co., Ltd., B & C Biopharm. Active years: 2007-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jae-Jin Han. Retrieved from https://idiyas.com/inventor/jae-jin-han

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 60.0

 

Average Co-Inventor Count = 1.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Yongin-si, KR (2007 - 2014)
  • Gyeonggi-do, KR (2014)

Company Filing History:

goldMedal3 out of 3 
 
Cellsafe Co., Ltd.
 patents
silverMedal2 out of 2 
 
B & C Biopharm
 patents

Years Active: 2007-2014

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents
1. 8871749 - Bone-transplant or bone-filling composition comprising a dihydroxybenzoic acid derivative (2014-10-28),
2. 8815565 - Method for culturing mycoplasma contamination-free cells and method for removing mycoplasma contamination of cells (2014-08-26),
3. 8809034 - [object Object] (2014-08-19),
4. 7276501 - 6-(4-substituted-anilino)pyrimidine derivatives, method for preparation thereof and antiviral pharmaceutical composition comprising the same (2007-10-02),
5. 7244731 - 6-Methylpyridine derivatives, method for preparing thereof and antiviral pharmaceutical composition comprising the same (2007-07-17),

Title: **Innovative Contributions of Inventor Jae-Jin Han in Biotechnology**

Introduction

Jae-Jin Han is a prominent inventor based in Yongin-si, South Korea, known for his significant contributions to the field of biotechnology. With a total of five patents to his name, he has demonstrated a commitment to advancing medical and scientific technologies that address critical challenges.

Latest Patents

One of Jae-Jin Han's notable inventions is a bone-transplant or bone-filling composition that comprises a dihydroxybenzoic acid derivative. This innovative composition has been shown to enhance osteoblast activity, thereby promoting bone formation, making it a potential game-changer in regenerative medicine. Another critical patent involves a method for culturing mycoplasma contamination-free cells and a method for removing mycoplasma contamination of cells. This technique utilizes biomass extracts from specific strains to prevent contamination, which is a common issue in cell culture processes. Additionally, the invention provides a solution for removing contaminated cells through an effective combination of treatment methods.

Career Highlights

Throughout his career, Jae-Jin Han has worked with leading organizations in the biotechnology sector, including Cellsafe Co., Ltd. and B & C Biopharm. His work has significantly impacted the development of new technologies that ensure safer and more effective laboratory practices.

Collaborations

Jae-Jin Han has collaborated with esteemed professionals in his field, such as Jong-Woo Kim and Sang-Wook Lee. These partnerships have fostered a rich exchange of ideas and expertise that contribute to innovative solutions in biotechnology.

Conclusion

Jae-Jin Han exemplifies the spirit of innovation that drives progress in the biotechnology sector. His patents not only showcase his inventive capabilities but also highlight his dedication to advancing healthcare solutions. As he continues to develop new technologies, his contributions will undoubtedly shape the future of medical treatments and laboratory practices.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…